UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Analysis of the flame retardant metabolites bis(1,3-dichloro-2-propyl) phosphate (BDCPP) and diphenyl phosphate (DPP) in urine using liquid chromatography–tandem mass spectrometry

Analytical and bioanalytical chemistry, 2011-10, Vol.401 (7), p.2123-2132

2011

Volltextzugriff (PDF)

Interaction of metabolic and haemodynamic factors in mediating experimental diabetic nephropathy

Diabetologia, 2001-11, Vol.44 (11), p.1957-1972

COOPER, M. E

2001

Volltextzugriff (PDF)

Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds

Diabetologia, 2012-03, Vol.55 (3), p.636-643

2012

Volltextzugriff (PDF)

Pharmacological inhibition of NOX reduces atherosclerotic lesions, vascular ROS and immune–inflammatory responses in diabetic Apoe−/− mice

Diabetologia, 2014-03, Vol.57 (3), p.633-642

2014

Volltextzugriff (PDF)

Advanced glycation of apolipoprotein A-I impairs its anti-atherogenic properties

Diabetologia, 2007-08, Vol.50 (8), p.1770-1779

2007

Volltextzugriff (PDF)

The endothelin receptor antagonist avosentan ameliorates nephropathy and atherosclerosis in diabetic apolipoprotein E knockout mice

Diabetologia, 2010-01, Vol.53 (1), p.192-203

2010

Volltextzugriff (PDF)

Urotensin II receptor antagonism confers vasoprotective effects in diabetes associated atherosclerosis: studies in humans and in a mouse model of diabetes

Diabetologia, 2013-05, Vol.56 (5), p.1155-1165

2013

Volltextzugriff (PDF)

Soluble receptor for AGE (RAGE) is a novel independent predictor of all-cause and cardiovascular mortality in type 1 diabetes

Diabetologia, 2011-10, Vol.54 (10), p.2669-2677

2011

Volltextzugriff (PDF)

Increased serum potassium affects renal outcomes: a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial

Diabetologia, 2011-01, Vol.54 (1), p.44-50

2011

Volltextzugriff (PDF)

Delayed intervention with AGE inhibitors attenuates the progression of diabetes-accelerated atherosclerosis in diabetic apolipoprotein E knockout mice

Diabetologia, 2011-03, Vol.54 (3), p.681-689

2011

Volltextzugriff (PDF)

Receptor for AGEs (RAGE) blockade may exert its renoprotective effects in patients with diabetic nephropathy via induction of the angiotensin II type 2 (AT2) receptor

Diabetologia, 2010-11, Vol.53 (11), p.2442-2451

2010

Volltextzugriff (PDF)

Monocyte chemoattractant protein-1 has prosclerotic effects both in a mouse model of experimental diabetes and in vitro in human mesangial cells

Diabetologia, 2008-01, Vol.51 (1), p.198-207

2008

Volltextzugriff (PDF)

Irbesartan normalises the deficiency in glomerular nephrin expression in a model of diabetes and hypertension

Diabetologia, 2001-07, Vol.44 (7), p.874-877

2001

Volltextzugriff (PDF)

HMG-CoA reductase inhibitor rosuvastatin and the angiotensin receptor antagonist candesartan attenuate atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes via effects on advanced glycation, oxidative stress and inflammation

Diabetologia, 2008-09, Vol.51 (9), p.1731-1740

2008

Volltextzugriff (PDF)

Renoprotective effects of a novel inhibitor of advanced glycation

Diabetologia, 2001-01, Vol.44 (1), p.108-114

2001

Volltextzugriff (PDF)

Angiotensin converting enzyme inhibition reduces retinal overexpression of vascular endothelial growth factor and hyperpermeability in experimental diabetes

Diabetologia, 2000-11, Vol.43 (11), p.1360-1367

2000

Volltextzugriff (PDF)

Angiotensin II subtype 2 receptor blockade and deficiency attenuate the development of atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes

Diabetologia, 2010-03, Vol.53 (3), p.584-592

2010

Volltextzugriff (PDF)

Receptor for advanced glycation end-products (RAGE) provides a link between genetic susceptibility and environmental factors in type 1 diabetes

Diabetologia, 2011-05, Vol.54 (5), p.1032-1042

2011

Volltextzugriff (PDF)

Gemfibrozil decreases atherosclerosis in experimental diabetes in association with a reduction in oxidative stress and inflammation

Diabetologia, 2006-04, Vol.49 (4), p.766-774

2006

Volltextzugriff (PDF)

Anaemia in diabetes : is there a rationale to TREAT?

Diabetologia, 2006-06, Vol.49 (6), p.1151-1157

2006

Volltextzugriff (PDF)

Plasminogen activator inhibitor-1 production is pathogenetic in experimental murine diabetic renal disease

Diabetologia, 2007-06, Vol.50 (6), p.1315-1326

2007

Volltextzugriff (PDF)

Cell division autoantigen 1 plays a profibrotic role by modulating downstream signalling of TGF-β in a murine diabetic model of atherosclerosis

Diabetologia, 2010, Vol.53 (1), p.170-179

2010

Volltextzugriff (PDF)

The time has come to target connective tissue growth factor in diabetic complications

Diabetologia, 2004-06, Vol.47 (6), p.965-968

2004

Volltextzugriff (PDF)

Podocyte foot process broadening in experimental diabetic nephropathy : amelioration with renin-angiotensin blockade

Diabetologia, 2001-07, Vol.44 (7), p.878-882

2001

Volltextzugriff (PDF)

Enalapril retards Glomerular basement membrane thickening and albuminuria in the diabetic rat

Diabetologia, 1989-05, Vol.32 (5), p.326-328

1989

Volltextzugriff (PDF)

1 – 25 von 770

Suche als RSS-Feed

Aktive Filter

KollektionSpringerLINK Contemporary (Konsortium Baden-Württemberg)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(754)
Mit Volltextzugriff
(756)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Analysis of the flame retardant metabolites bis(1,3-dichloro-2-propyl) phosphate (BDCPP) and diphenyl phosphate (DPP) in urine using liquid chromatography–tandem mass spectrometry

Interaction of metabolic and haemodynamic factors in mediating experimental diabetic nephropathy

Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds

Pharmacological inhibition of NOX reduces atherosclerotic lesions, vascular ROS and immune–inflammatory responses in diabetic Apoe−/− mice

Advanced glycation of apolipoprotein A-I impairs its anti-atherogenic properties

The endothelin receptor antagonist avosentan ameliorates nephropathy and atherosclerosis in diabetic apolipoprotein E knockout mice

Urotensin II receptor antagonism confers vasoprotective effects in diabetes associated atherosclerosis: studies in humans and in a mouse model of diabetes

Soluble receptor for AGE (RAGE) is a novel independent predictor of all-cause and cardiovascular mortality in type 1 diabetes

Increased serum potassium affects renal outcomes: a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial

Delayed intervention with AGE inhibitors attenuates the progression of diabetes-accelerated atherosclerosis in diabetic apolipoprotein E knockout mice

Receptor for AGEs (RAGE) blockade may exert its renoprotective effects in patients with diabetic nephropathy via induction of the angiotensin II type 2 (AT2) receptor

Monocyte chemoattractant protein-1 has prosclerotic effects both in a mouse model of experimental diabetes and in vitro in human mesangial cells

Irbesartan normalises the deficiency in glomerular nephrin expression in a model of diabetes and hypertension

HMG-CoA reductase inhibitor rosuvastatin and the angiotensin receptor antagonist candesartan attenuate atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes via effects on advanced glycation, oxidative stress and inflammation

Renoprotective effects of a novel inhibitor of advanced glycation

Angiotensin converting enzyme inhibition reduces retinal overexpression of vascular endothelial growth factor and hyperpermeability in experimental diabetes

Angiotensin II subtype 2 receptor blockade and deficiency attenuate the development of atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes

Receptor for advanced glycation end-products (RAGE) provides a link between genetic susceptibility and environmental factors in type 1 diabetes

Gemfibrozil decreases atherosclerosis in experimental diabetes in association with a reduction in oxidative stress and inflammation

Anaemia in diabetes : is there a rationale to TREAT?

Plasminogen activator inhibitor-1 production is pathogenetic in experimental murine diabetic renal disease

Cell division autoantigen 1 plays a profibrotic role by modulating downstream signalling of TGF-β in a murine diabetic model of atherosclerosis

The time has come to target connective tissue growth factor in diabetic complications

Podocyte foot process broadening in experimental diabetic nephropathy : amelioration with renin-angiotensin blockade

Enalapril retards Glomerular basement membrane thickening and albuminuria in the diabetic rat

Aktive Filter

Suchergebnisse filtern